AI Business

Synthpop Secures $15M Series A to Enhance AI-Driven Healthcare Automation

Synthpop secures $15M in Series A funding to enhance its AI platform, automating 80% of healthcare workflows and reducing processing times from 40 minutes to under one minute.

Marcus Chen

Published

1 hour ago

Synthpop, Inc. has secured $15 million in Series A funding, led by Ansa Capital, bringing its total funding to $23 million. This new capital will enable the healthcare AI company to enhance its multi-agent platform designed to streamline administrative workflows in healthcare settings. Major participants in this funding round included Defy.vc, Peterson Ventures, and Storm Ventures.

The platform developed by Synthpop automates complex processes such as referrals, prior authorizations, eligibility checks, and claims processing by integrating seamlessly with electronic health records (EHR), billing systems, and e-prescription platforms. CEO Elad Ferber noted that the funding will facilitate further integrations and product enhancements while expanding their coverage in the healthcare sector. Over the past year, Synthpop has achieved remarkable traction, processing more than 2 million patient workflows.

“Point solutions can’t fix operational bottlenecks,” Ferber stated. “Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software.” This approach has proven effective, as the company reports that workflows traditionally requiring 40 minutes are now completed in under one minute, all while significantly reducing costs compared to traditional human labor.

Synthpop’s technology combines document intelligence, payer-aware reasoning, and conversational voice agents into an integrated system capable of automating up to 80% of healthcare business processes. This innovation not only lightens the administrative load but also improves patient care by speeding up service delivery and reducing the likelihood of claim denials. Established organizations across various sectors, including Durable Medical Equipment (DME) and fertility health, have already reported significant operational improvements after implementing Synthpop’s solutions.

Marco DeMeireles, Co-Founder and Managing Partner at Ansa Capital, expressed enthusiasm about the investment, emphasizing the necessity of AI-native solutions in overcoming the manual workflow challenges that have long plagued healthcare organizations. “The early value delivered to customers has been extremely compelling,” he said, signaling a strong belief in Synthpop’s potential to revolutionize healthcare operations.

In addition to its funding success, Synthpop recently augmented its team by hiring key talent from the airt team, including Davor Runje and Hajdi Cenan. Both have a rich background in developing AI technologies and contributed to Microsoft’s open-source framework for building agentic AI applications. This strategic hire is expected to accelerate Synthpop’s capabilities in automating healthcare workflows.

Medha Agarwal, General Partner at Defy.vc, highlighted the unique position Synthpop holds in the market. “We’ve been impressed by their progress as investors, and we’re excited to double down,” she said. “Their multi-agent platform delivers immediate, measurable value for providers, dramatically reducing time, cost, and friction across the patient journey.” The focus on leveraging AI to improve healthcare access and efficiency is increasingly relevant amid rising patient demand.

Founded in 2023 by Ferber and Jan Jannink, PhD, Synthpop aims to eliminate administrative friction in healthcare operations through its API-first, multi-agent system. Both founders bring substantial experience from previous ventures, with Ferber co-founding Spry Health and Jannink having co-founded notable companies like imeem and VoiceBase. Their combined expertise positions Synthpop to address the intricate challenges of healthcare administration effectively.

Synthpop is SOC 2-audited and fully HIPAA compliant, ensuring that it adheres to the highest standards of data security and privacy, which is critical in the healthcare field. The company plans to continue expanding its team and product capabilities with the funds raised, tapping into additional healthcare verticals to broaden its impact.

As healthcare organizations increasingly seek efficient, AI-driven solutions to meet growing demands, Synthpop’s innovative approach is poised to play a significant role in shaping the future of healthcare operations, ultimately enhancing patient access to care.